目的:以扁桃体隐窝内甲型链球菌(HS)灭活菌株刺激IgA肾病(IgAN)患者和非肾炎患者扁桃体淋巴细胞,观察未刺激及刺激后CD4+CD25+细胞和分泌J链IgA细胞数量,探讨IgAN的发病机制。方法:(1)收集37例IgAN患者及37例非肾炎慢性扁桃体炎患者手...目的:以扁桃体隐窝内甲型链球菌(HS)灭活菌株刺激IgA肾病(IgAN)患者和非肾炎患者扁桃体淋巴细胞,观察未刺激及刺激后CD4+CD25+细胞和分泌J链IgA细胞数量,探讨IgAN的发病机制。方法:(1)收集37例IgAN患者及37例非肾炎慢性扁桃体炎患者手术摘除的扁桃体;(2)分离鉴定两组患者扁桃体隐窝内细菌及分离培养扁桃体淋巴细胞;(3)以分离最多的灭活菌株HS体外刺激扁桃体淋巴细胞72h;(4)以流式细胞仪检测扁桃体淋巴细胞CD4+CD25+细胞数,以原位杂交技术检测J链mRNA表达,以免疫荧光及荧光原位杂交技术同步分析分泌J链IgA细胞。结果:(1)两组患者均有甲型链球菌,且甲型链球菌在分离的细菌中是最多的。两组患者的细菌谱和细菌量无统计学差异。(2)未刺激、非肾炎患者HS(HS-controls)、IgAN患者HS(HS-IgAN)刺激后CD4+CD25+细胞数[(0.98±0.204)% vs (3.58±0.554)%,P<0.05,(1.37±0.214)% vs (5.78±0.562)%,P<0.05,and(1.43±0.202)% vs (6.05±0.521)%,P<0.05],IgAN组与非肾炎组比较,前者均显著低于后者。HS对IgAN组CD4+CD25+细胞的刺激指数(stimulation index,SI)显著低于非肾炎组(P均<0.05)。(3)未刺激、HS-controls、HS-IgAN刺激后J链mRNA阳性IgA细胞[(11.9±3.1)% vs (6.5±1.5)%,P<0.05,(33.5±5.7)% vs (13.9±1.2)%,P<0.05,and(35.1±6.2)% vs (13.9±1.2)%,P<0.01],IgAN组与非肾炎组比较,前者均显著高于后者。HS对IgAN组J链mRNA阳性IgA细胞的SI显著高于非肾炎组(P均<0.01)。(4)HS对CD4+CD25+细胞的SI与对分泌J链IgA细胞的SI呈显著性负相关(P均<0.01)。结论:IgAN患者扁桃体CD4+CD25+细胞减少和分泌J链IgA细胞增多可能与IgAN的发病机制有关。展开更多
Background:Since the overuse of antibiotics in animal production has led to a selection of antibiotic-resistant pathogens that affect humans and animals as well.Scientists are therefore searching for novel natural alt...Background:Since the overuse of antibiotics in animal production has led to a selection of antibiotic-resistant pathogens that affect humans and animals as well.Scientists are therefore searching for novel natural alternatives to antibiotics.In this study Lactobacillus reuteri and a combination of reuterin and microcin J25(RJ)were evaluated as promoters of growth and modulators of the cecal microbiota and metabolite profiles in broiler chickens.Oneday-old Cobb 500 male broilers were distributed to 8 treatments:negative control(without antibiotic),positive control(bacitracin),three concentrations of RJ and three doses of L.reuteri plus glycerol.The birds(2176,34 per pen,8 pens per treatment)were reared for 35 d.Results:The body weight of the bacitracin and 5 mmol/L reuterin combined with 0.08μmol/L microcin J25(10RJ)treatment group was significantly higher than that of the negative control group(P<0.05).L.reuteri had no significant effect on broiler growth.MiSeq high-throughput sequencing of 16S rRNA showed clustering of cecal microbial operational taxonomic unit diversity according to treatment.The influence of bacitracin and 10RJ on bacterial community overall structure was similar.They promoted Ruminococcaceae,Lachnospiraceae and Lactobacillaceae,increased the relative abundance of Faecalibacterium and decreased the abundance of Bacteroides and Alistipes,while the negative control condition favored Bacteroidaceae and Rikenellaceae.Furthermore,10RJ increased the concentration of short-chain fatty acid in the cecum and changed the metabolome overall.Conclusions:These overall suggest that 10RJ can promote a host-friendly gut environment by changing the cecal microbiome and metabolome.This combination of natural antimicrobial agents in the drinking water had a positive effect on broiler growth and may be suitable as an alternative to antibiotic growth promoters.展开更多
A new cytotoxic saponin(1). Julibrosides J(27), was isolated from the stem barks of Alibizia. julibrissin by chromatography, and the structure was elucidated as 3-O-beta-D-xylopyranosyl-(1-->2)-beta -D- fucopyranos...A new cytotoxic saponin(1). Julibrosides J(27), was isolated from the stem barks of Alibizia. julibrissin by chromatography, and the structure was elucidated as 3-O-beta-D-xylopyranosyl-(1-->2)-beta -D- fucopyranosyl - (1-->6) -beta -D-glucopyranosyl - 21-O-[(6S)-2 -trans-2-hydroxymethyl-6-methyl-6-O- [4-O-((6S)-2-trans-2-hydroxylmethy 6- methyl - 6- hydroxy)-2,7-octadienoyl-beta-D-quinovopy- -ranosyl]-2.7-octadienoyl}- acacic acid- 28 -O-beta-D-glucopranosyl-(1-->3)-[(alpha-L-arabinofuranosyl-(1-->4)]-alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyrnosyl ester based on spectral and chemical evidences.展开更多
The overuse and misuse of traditional antimicrobial drugs have led to their weakened effectiveness and the emergence of pathogenic bacterial resistance.Consequently,there has been growing interest in alternative op-ti...The overuse and misuse of traditional antimicrobial drugs have led to their weakened effectiveness and the emergence of pathogenic bacterial resistance.Consequently,there has been growing interest in alternative op-tions such as antimicrobial peptides(AMPs)in the pharmaceutical industry.Microcin J25(MccJ25)has gained significant attention for its potent inhibitory effect on a diverse range of pathogens.Its unique rotaxane structure provides exceptional stability against extreme thermal,pH,and protease degradation,including chymotrypsin,trypsin,and pepsin.Given its remarkable stability and diverse bioactivity,we aim to provide an overview of the physicochemical properties,the mechanism underlying its antimicrobial activity,and the critical functional residues of MccJ25.Additionally,we have summarized the latest strategies for the heterologous expression of MccJ25,and its potential medical use and other applications.展开更多
文摘目的:以扁桃体隐窝内甲型链球菌(HS)灭活菌株刺激IgA肾病(IgAN)患者和非肾炎患者扁桃体淋巴细胞,观察未刺激及刺激后CD4+CD25+细胞和分泌J链IgA细胞数量,探讨IgAN的发病机制。方法:(1)收集37例IgAN患者及37例非肾炎慢性扁桃体炎患者手术摘除的扁桃体;(2)分离鉴定两组患者扁桃体隐窝内细菌及分离培养扁桃体淋巴细胞;(3)以分离最多的灭活菌株HS体外刺激扁桃体淋巴细胞72h;(4)以流式细胞仪检测扁桃体淋巴细胞CD4+CD25+细胞数,以原位杂交技术检测J链mRNA表达,以免疫荧光及荧光原位杂交技术同步分析分泌J链IgA细胞。结果:(1)两组患者均有甲型链球菌,且甲型链球菌在分离的细菌中是最多的。两组患者的细菌谱和细菌量无统计学差异。(2)未刺激、非肾炎患者HS(HS-controls)、IgAN患者HS(HS-IgAN)刺激后CD4+CD25+细胞数[(0.98±0.204)% vs (3.58±0.554)%,P<0.05,(1.37±0.214)% vs (5.78±0.562)%,P<0.05,and(1.43±0.202)% vs (6.05±0.521)%,P<0.05],IgAN组与非肾炎组比较,前者均显著低于后者。HS对IgAN组CD4+CD25+细胞的刺激指数(stimulation index,SI)显著低于非肾炎组(P均<0.05)。(3)未刺激、HS-controls、HS-IgAN刺激后J链mRNA阳性IgA细胞[(11.9±3.1)% vs (6.5±1.5)%,P<0.05,(33.5±5.7)% vs (13.9±1.2)%,P<0.05,and(35.1±6.2)% vs (13.9±1.2)%,P<0.01],IgAN组与非肾炎组比较,前者均显著高于后者。HS对IgAN组J链mRNA阳性IgA细胞的SI显著高于非肾炎组(P均<0.01)。(4)HS对CD4+CD25+细胞的SI与对分泌J链IgA细胞的SI呈显著性负相关(P均<0.01)。结论:IgAN患者扁桃体CD4+CD25+细胞减少和分泌J链IgA细胞增多可能与IgAN的发病机制有关。
基金the Natural Sciences and Engineering Research Council (NSERC) of Canada industrial research chair METABIOLAC (grant number IRCPJ 499946–15)from Agriculture and Agri-Food Canada (project PSS#1781, J-002308)
文摘Background:Since the overuse of antibiotics in animal production has led to a selection of antibiotic-resistant pathogens that affect humans and animals as well.Scientists are therefore searching for novel natural alternatives to antibiotics.In this study Lactobacillus reuteri and a combination of reuterin and microcin J25(RJ)were evaluated as promoters of growth and modulators of the cecal microbiota and metabolite profiles in broiler chickens.Oneday-old Cobb 500 male broilers were distributed to 8 treatments:negative control(without antibiotic),positive control(bacitracin),three concentrations of RJ and three doses of L.reuteri plus glycerol.The birds(2176,34 per pen,8 pens per treatment)were reared for 35 d.Results:The body weight of the bacitracin and 5 mmol/L reuterin combined with 0.08μmol/L microcin J25(10RJ)treatment group was significantly higher than that of the negative control group(P<0.05).L.reuteri had no significant effect on broiler growth.MiSeq high-throughput sequencing of 16S rRNA showed clustering of cecal microbial operational taxonomic unit diversity according to treatment.The influence of bacitracin and 10RJ on bacterial community overall structure was similar.They promoted Ruminococcaceae,Lachnospiraceae and Lactobacillaceae,increased the relative abundance of Faecalibacterium and decreased the abundance of Bacteroides and Alistipes,while the negative control condition favored Bacteroidaceae and Rikenellaceae.Furthermore,10RJ increased the concentration of short-chain fatty acid in the cecum and changed the metabolome overall.Conclusions:These overall suggest that 10RJ can promote a host-friendly gut environment by changing the cecal microbiome and metabolome.This combination of natural antimicrobial agents in the drinking water had a positive effect on broiler growth and may be suitable as an alternative to antibiotic growth promoters.
文摘A new cytotoxic saponin(1). Julibrosides J(27), was isolated from the stem barks of Alibizia. julibrissin by chromatography, and the structure was elucidated as 3-O-beta-D-xylopyranosyl-(1-->2)-beta -D- fucopyranosyl - (1-->6) -beta -D-glucopyranosyl - 21-O-[(6S)-2 -trans-2-hydroxymethyl-6-methyl-6-O- [4-O-((6S)-2-trans-2-hydroxylmethy 6- methyl - 6- hydroxy)-2,7-octadienoyl-beta-D-quinovopy- -ranosyl]-2.7-octadienoyl}- acacic acid- 28 -O-beta-D-glucopranosyl-(1-->3)-[(alpha-L-arabinofuranosyl-(1-->4)]-alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyrnosyl ester based on spectral and chemical evidences.
基金supported by grants from National Key R&D Pro-gram of China(2019YFA0905200)Natural Science Foundation Youth Project of Jiangsu Province(BK20220335)the Jiangsu Synergetic Innovation Center for Advanced Bio-Manufacture(NO.XTC2206).
文摘The overuse and misuse of traditional antimicrobial drugs have led to their weakened effectiveness and the emergence of pathogenic bacterial resistance.Consequently,there has been growing interest in alternative op-tions such as antimicrobial peptides(AMPs)in the pharmaceutical industry.Microcin J25(MccJ25)has gained significant attention for its potent inhibitory effect on a diverse range of pathogens.Its unique rotaxane structure provides exceptional stability against extreme thermal,pH,and protease degradation,including chymotrypsin,trypsin,and pepsin.Given its remarkable stability and diverse bioactivity,we aim to provide an overview of the physicochemical properties,the mechanism underlying its antimicrobial activity,and the critical functional residues of MccJ25.Additionally,we have summarized the latest strategies for the heterologous expression of MccJ25,and its potential medical use and other applications.